BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Adbry (tralokinumab) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Adbry (tralokinumab)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07352566-1509@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20300601
DTEND;VALUE=DATE:20300602
SUMMARY:Adbry (tralokinumab): Phase 4 readout est. (NCT07352566)
DESCRIPTION:Adbry (tralokinumab)\, phase 4\, Atopic Dermatitis.\nStudy: Uti
 lization of a Microdevice for Psoriasis and Atopic Dermatitis\nEstimated p
 rimary completion: 1 June 2030. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/tralokinumab#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07352566
URL:https://assetmemo.bio/drug/tralokinumab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
